The Pfizer Vaccines US Medical Affairs Team invites you to attend an educational webinar series. It is designed to communicate scientific information which may include recent study results to inform healthcare providers regarding Pfizer's RSV vaccine.
The webinar series will include a live question-and-answer session with Pfizer medical experts.
We are hosting a Ready for RSV session on the topic below
RSV Vaccine Updates for Adults
18-59 Years of Age
Wednesday, November 13, 2024,
12:00 p.m. ET
Speaker: Robyn Moucka, PharmD
Medical Director, Pfizer Vaccines US Medical Affairs
Intended Audience: US healthcare professionals including but not limited to physicians, nurse practitioners, pharmacists, and physician assistants.
Continuing medical education credit is NOT associated with this event.